IV infusion therapy results are immediate and patients would be able to recover at home as well as experience shortened illness duration, according to a statement.
“IV infusion therapy allows patients to spend less time receiving treatment while decreasing the risk of infection. Outpatient treatment not only lowers medical costs, but also allows patients to return to their daily lives and spend more time with their friends and family,” said Umar Saeed, MD.
More articles on ASC issues:
How to turn ASC staffing from a cost-center into a value center – 8 key steps
Healthcare services M&A: 10 key trends
Did the ASC industry end the year with a bang or a bust? 50 things to know about 4Q, year-end financial results
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
